Follow-Up Extension to the Family Study of Binge Eating Disorder
- Conditions
- Binge Eating Disorder
- Interventions
- Other: No intervention.
- Registration Number
- NCT00777634
- Lead Sponsor
- Mclean Hospital
- Brief Summary
This study involves a 2.5 and 5 year follow-up interview for individuals who participated in the initial family study of binge eating disorder. The study includes individuals with and without eating disorder as well as their first degree relatives. As part of the study, participants will be interviewed about their current psychiatric and medical symptoms, their blood pressure will be measured, and laboratory specimens will be obtained.
- Detailed Description
Previously we completed a family interview study of 150 individuals with binge eating disorder, 150 matched controls, and approximately 888 of their first degree relatives. In follow-up to this, we are interviewing these individuals again at 2.5 and 5 years after their initial interview. During the course of the interview, individuals are asked about their psychiatric and medical history and blood pressure and laboratory specimens are obtained to measure, among other things, fasting lipids and glucose.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 268
- Individuals with or without binge eating disorder and their family members who participated in the initial family study of binge eating disorder and agree to be followed up at 2.5 and 5 years.
- Unwilling or unable to participate in the follow-up study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Without BED No intervention. Individuals who do not meet criteria for binge eating disorder. Binge eating disorder (BED) No intervention. Individuals who meet criteria for binge eating disorder.
- Primary Outcome Measures
Name Time Method Incidence of Diagnosis of Any Metabolic Syndrome Component Baseline to 5 years The number of participants to acquire a new diagnosis of one component of metabolic syndrome. Metabolic syndrome can include abdominal obesity, high blood pressure, high cholesterol, etc.
Incidence of Diagnosis of Dyslipidemia Baseline to 5 years The number of participants to acquire a new diagnosis of high cholesterol (dyslipidemia) over the course of the baseline to five-year followup.
Incidence of Diagnosis of Hypertension Baseline to 5 years The number of participants to acquire a new diagnosis of high blood pressure(hypertension) over the course of the baseline to five-year followup.
Incidence of Diagnosis of Type 2 Diabetes Baseline to 5 years The number of participants to acquire a new diagnosis of Type 2 Diabetes over the course of the baseline to five-year followup.
Incidence of Diagnosis of Three or More Metabolic Syndrome Components Baseline to 5 years The number of participants to acquire a new diagnosis of three or more components of metabolic syndrome. Metabolic syndrome can include abdominal obesity, high blood pressure, high cholesterol, etc.
Incidence of Diagnosis of Two or More Metabolic Syndrome Components Baseline to 5 years The number of participants to acquire a new diagnosis of two or more components of metabolic syndrome. Metabolic syndrome can include abdominal obesity, high blood pressure, high cholesterol, etc.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
McLean Hospital
🇺🇸Belmont, Massachusetts, United States